Last viewed: GOVX


Prices are updated after-hours



nasdaq:GOVX GeoVax Labs, Inc.

GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-33.8% 1m) (-47.4% 1y) (0.0% 2d) (-0.8% 3d) (-5.7% 7d) (9.65% volume)
http://www.geovax.com
Sec Filling | Patents | 6 employees

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and cancer using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. Hildebrand on September 9, 2006 and is headquartered in Smyrna, GA.

add to today's watch list email alert is off




vaccine   cancer   immunotherapy   infectious disease  

Press-releases


DNA Vaccine Market Size to Grow $774.43 Million, Globally, by 2030 at 6.3% CAGR: AMR
Published: 2022-01-18 (Crawled : 09:00) - prnewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -4.29% H: 4.48% C: -0.75%
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: 1.47% H: 0.0% C: 0.0%
ZTS | News | $203.68 | twitter stocktwits trandingview |
Health Technology
| | O: -2.28% H: 0.0% C: 0.0%

vaccine
GeoVax Announces $10 Million Private Placement
Published: 2022-01-14 (Crawled : 14:00) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -10.54% H: 0.0% C: 0.0%

ces
GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress
Published: 2021-12-03 (Crawled : 14:30) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -2.3% H: 2.06% C: -3.66%

era immunotherapy therapy vaccine
GeoVax to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Published: 2021-09-07 (Crawled : 13:15) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -1.74% H: 0.53% C: -6.9%

conference
GeoVax to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021
Published: 2021-08-12 (Crawled : 13:15) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: 1.3% H: 0.23% C: -5.12%


GeoVax Announces Presentation of Sudan Ebolavirus Vaccine Data at the American Society for Virology Annual Meeting
Published: 2021-07-22 (Crawled : 13:15) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: 10.14% H: 3.97% C: -3.56%

presentation vaccine
GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium
Published: 2021-06-10 (Crawled : 15:15) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: 1.88% H: 2.03% C: 0.55%


GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update
Published: 2021-04-26 (Crawled : 13:15) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -0.21% H: 3.38% C: 3.38%

financial results results
GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update
Published: 2021-03-23 (Crawled : 21:00) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: 2.87% H: 4.24% C: -2.59%

financial results results
GeoVax to Report 2020 Financial Results on Tuesday, March 23, 2021 and Provide Corporate Update
Published: 2021-03-15 (Crawled : 14:00) - globenewswire.com
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: 2.95% H: 1.77% C: -0.19%

financial results results
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying